Circular RNA ATP9A Stimulates Non-small Cell Lung Cancer Progression via MicroRNA-582-3p/Ribosomal Protein Large P0 Axis and Activating Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway
- PMID: 39832103
- DOI: 10.1007/s12010-024-05159-z
Circular RNA ATP9A Stimulates Non-small Cell Lung Cancer Progression via MicroRNA-582-3p/Ribosomal Protein Large P0 Axis and Activating Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway
Abstract
Circular RNAs (circRNAs), along with their pathogenic property in non-small cell lung cancer (NSCLC), require comprehensive analyses and explanations. The study is established with the purpose to elucidate the potential molecular mechanism of circATP9A in NSCLC. CircATP9A and microRNA (miR)-582-3p were evaluated by real-time quantitative polymerase chain reaction, and ribosomal protein large P0 (RPLP0), cleaved caspase-3, cleaved Ki-67, epithelial-to-mesenchymal transition (EMT)-associated proteins (N-cadherin and E-cadherin), and core proteins of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway were by Western blot. The processes of proliferation, apoptosis, migration, and invasion were measured by cell counting kit-8, 5-ethynyl-2'deoxyuridine, flow cytometry, and Transwell. Gene interaction was verified by RNA immunoprecipitation and dual luciferase reporter assay. CircATP9A and RPLP0 were abnormally highly expressed in both NSCLC tissues and cell lines, while miR-582-3p was abnormally low. Knockdown of circATP9A reduced NSCLC proliferation, invasion migration, and EMT and promoted apoptosis. This was further validated in nude mouse xenograft experiments. The inhibitory effect of knockdown of circATP9A on NSCLC was reversed by knockdown of miR-582-3p. In addition, the promoting effect of overexpression of circATP9A on NSCLC was reversed by knockdown of RPLP0. Mechanistically, circATP9A acted as a competitive endogenous RNA, sequestering miR-582-3p away from its target, which in turn modulated the expression of RPLP0. CircATP9A activated the miR-582-3p/RPLP0 axis by regulating the PI3K/Akt pathway in NSCLC cells. CircATP9A stimulates NSCLC progression via miR-582-3p/RPLP0 axis and PI3K/AKT cascade activation.
Keywords: NSCLC circATP9A; miR-582-3p; RPLP0.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: The present study was approved by the Ethics Committee of The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine. All procedures were performed in accordance with the ethical standards of the Institutional Review Board and The Declaration of Helsinki, and its later amendments or comparable ethical standards. And all procedures complied with the National Institutes of Health Guide for the Use of Laboratory Animals. Consent to Participate: Written informed consent was provided by all patients prior to the study start. Consent for Publication: Written informed consent for publication was obtained from all participants. Competing Interests: The authors declare no competing interests.
Similar articles
-
Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.Biomed Pharmacother. 2020 Sep;129:110461. doi: 10.1016/j.biopha.2020.110461. Epub 2020 Jul 16. Biomed Pharmacother. 2020. PMID: 32768951
-
Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p.J Bioenerg Biomembr. 2021 Apr;53(2):223-233. doi: 10.1007/s10863-021-09876-6. Epub 2021 Mar 9. J Bioenerg Biomembr. 2021. PMID: 33687619
-
Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8391-8402. doi: 10.26355/eurrev_201910_19150. Eur Rev Med Pharmacol Sci. 2019. PMID: 31646569
-
CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.Mol Cancer. 2023 Nov 6;22(1):179. doi: 10.1186/s12943-023-01888-7. Mol Cancer. 2023. PMID: 37932766 Free PMC article.
-
Unraveling the role of miR-767 in tumor progression: Mechanisms and clinical implications.Gene. 2025 May 15;949:149366. doi: 10.1016/j.gene.2025.149366. Epub 2025 Feb 27. Gene. 2025. PMID: 40023339 Review.
Cited by
-
Clinical significance and biological function of PRKCQ-AS1/miR-582-3p expression in LUAD.Hereditas. 2025 Jul 1;162(1):116. doi: 10.1186/s41065-025-00482-9. Hereditas. 2025. PMID: 40597380 Free PMC article.
References
-
- Reck, M., et al. (2014). Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis treatment and follow-up. Annals Oncology, 25(Suppl 3), iii27-39. - DOI
-
- Li, C., et al. (2019). Circular RNAs: Pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer. Journal Cancer Research Clinics Oncology, 145(12), 2875–2889. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials